702
Views
16
CrossRef citations to date
0
Altmetric
Author's View

Hormesis in cancer immunology

Does the quantity of an immune reactant matter?

, , &
Article: e29312 | Received 20 May 2014, Accepted 21 May 2014, Published online: 25 Jun 2014

References

  • Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature 2011; 480:480 - 9; http://dx.doi.org/10.1038/nature10673; PMID: 22193102
  • Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci 2012; 125:5591 - 6; http://dx.doi.org/10.1242/jcs.116392; PMID: 23420197
  • Andreu P, Johansson M, Affara NI, Pucci F, Tan T, Junankar S, Korets L, Lam J, Tawfik D, DeNardo DG, et al. FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 2010; 17:121 - 34; http://dx.doi.org/10.1016/j.ccr.2009.12.019; PMID: 20138013
  • Wu X, Ragupathi G, Panageas K, Hong F, Livingston PO. Accelerated tumor growth mediated by sublytic levels of antibody-induced complement activation is associated with activation of the PI3K/AKT survival pathway. Clin Cancer Res 2013; 19:4728 - 39; http://dx.doi.org/10.1158/1078-0432.CCR-13-0088; PMID: 23833306
  • Pearce OM, Läubli H, Verhagen A, Secrest P, Zhang J, Varki NM, Crocker PR, Bui JD, Varki A. Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies. Proc Natl Acad Sci U S A 2014; 111:5998 - 6003; http://dx.doi.org/10.1073/pnas.1209067111; PMID: 24711415
  • Prehn RT. The initial immune reaction to a new tumor antigen is always stimulatory and probably necessary for the tumor’s growth. Clin Dev Immunol 2010; 2010; http://dx.doi.org/10.1155/2010/851728; PMID: 20811480
  • Bui JD, Schreiber RD. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?. Curr Opin Immunol 2007; 19:203 - 8; http://dx.doi.org/10.1016/j.coi.2007.02.001; PMID: 17292599
  • Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, Mantovani A. Macrophage polarization in tumour progression. Semin Cancer Biol 2008; 18:349 - 55; http://dx.doi.org/10.1016/j.semcancer.2008.03.004; PMID: 18467122
  • Calabrese EJ. Hormesis and medicine. Br J Clin Pharmacol 2008; 66:594 - 617; PMID: 18662293
  • Hainsworth JD, Burris HA 3rd, Morrissey LH, Litchy S, Scullin DC Jr., Bearden JD 3rd, Richards P, Greco FA. Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma. Blood 2000; 95:3052 - 6; PMID: 10807768

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.